Skip to main content
Top
Published in: Supportive Care in Cancer 8/2010

01-08-2010 | Letter to the Editor

Increased blood culture sensitivity in pediatric oncology patients: is it the peripheral culture or increased collected blood volume?

Author: Thomas V. Adamkiewicz

Published in: Supportive Care in Cancer | Issue 8/2010

Login to get access

Excerpt

Scheinemann et al. [3] re-examined retrospectively the occurrence of central vs. peripheral blood cultures on the same oncology ward where a similar study was conducted previously [1]. The principal observation from the original study was that peripheral blood cultures were seldom clinically useful as a means to identify central line infections. However, both studies showed that the addition of a peripheral culture overall improves sensitivity to detect true pathogens. As Scheinemann et al. pointed out, it is possible that the same could have been achieved by drawing a larger blood draw from a single site. Indeed, in a recent study, pediatric blood cultures with measured volume ≥4 ml in children ≥36 months yielded significantly more positive results [2]. Scheinemann et al. defined 1 to 3 ml as an adequate collection volume, at time of collection. Volumes were not confirmed after collection. Adding a peripheral culture would have doubled the total volume collected and increased the likelihood of recovering a pathogen. Also, peripheral blood cultures contributed to the cumulative likelihood of isolating contaminants, thus the lowering of overall specificity. In the context where optimal blood volumes are collected from central lines, the utility of peripheral blood cultures still can be questioned. A well-designed prospective study to help determine best blood culture collection practices in pediatric oncology patients is needed. Effects of volume, timing (single vs. tandem draw), and site (central vs. peripheral) would be examined separately. Such a study should include sampling before and after start of antibiotic therapy, as positive culture rates remain significant after antibiotics are started [1], and presence of antibiotics may change culture recovery conditions. Such a study could include repeated central line cultures as control, an approach that could also help identify contaminants. …
Literature
1.
go back to reference Adamkiewicz TV, Lorenzana A, Doyle J, Richardson S (1999) Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward. Pediatr Infect Dis J 18(6):556–558CrossRefPubMed Adamkiewicz TV, Lorenzana A, Doyle J, Richardson S (1999) Peripheral vs. central blood cultures in patients admitted to a pediatric oncology ward. Pediatr Infect Dis J 18(6):556–558CrossRefPubMed
2.
go back to reference Connell TG, Rele M, Cowley D, Buttery JP, Curtis N (2007) How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 119(5):891–896CrossRefPubMed Connell TG, Rele M, Cowley D, Buttery JP, Curtis N (2007) How reliable is a negative blood culture result? Volume of blood submitted for culture in routine practice in a children's hospital. Pediatrics 119(5):891–896CrossRefPubMed
3.
go back to reference Scheinemann K, Ethier MC, Dupuis LL, Richardson SE, Doyle J, Allen U, Sung L (2009) Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer. doi:10.1007/s00520-009-0725-0 Scheinemann K, Ethier MC, Dupuis LL, Richardson SE, Doyle J, Allen U, Sung L (2009) Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer. doi:10.​1007/​s00520-009-0725-0
Metadata
Title
Increased blood culture sensitivity in pediatric oncology patients: is it the peripheral culture or increased collected blood volume?
Author
Thomas V. Adamkiewicz
Publication date
01-08-2010
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 8/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0872-3

Other articles of this Issue 8/2010

Supportive Care in Cancer 8/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine